MicroRNAs and response to therapy in leukemia
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.28892
Abstract: A variety of epigenetic factors involved in leukemia pathogenesis. Among various epigenetic factors, microRNAs (miRNAs) have emerged as important players, which affect a sequence of cellular and molecular signaling pathways. Leukemia is known as progressive… read more here.
Keywords: therapy; response therapy; patients leukemia; therapy patients ... See more keywords
Analysis of potential biomarkers of response to IL‐12 therapy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Leukocyte Biology"
DOI: 10.1002/jlb.5ru1221-675r
Abstract: IL‐12 is a proinflammatory cytokine capable of inducing a wide range of effects on both innate and adaptive immune responses. Its stimulatory effects on T cells and NK cells have led to its classification as… read more here.
Keywords: potential biomarkers; clinical trials; analysis potential; therapy ... See more keywords
Response to Therapy Status Is an Excellent Predictor of Pregnancy-Associated Structural Disease Progression in Patients Previously Treated for Differentiated Thyroid Cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Thyroid"
DOI: 10.1089/thy.2016.0501
Abstract: Background: Pregnancy may be associated with an increased risk of recurrence/progression of differentiated thyroid cancer (DTC). However, it is unclear if the impact of pregnancy would differ based on pre-pregnancy response to therapy status. The… read more here.
Keywords: progression; pregnancy; response therapy; thyroid cancer ... See more keywords
Natural Course of the American Thyroid Association Response to Therapy Statuses (Dynamic Risk Stratification) in Differentiated Thyroid Cancer
Sign Up to like & getrecommendations! Published in 2020 at "European Thyroid Journal"
DOI: 10.1159/000511708
Abstract: The concept of response to therapy in differentiated thyroid cancer (DTC) was introduced as a dynamic risk stratification used to assess the status of the disease at the time of the evaluation during the follow-up… read more here.
Keywords: status; incomplete status; response; structurally incomplete ... See more keywords
Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvaa178
Abstract: Abstract Context Controversy surrounds the extent and intensity of the management of American Thyroid Association (ATA) intermediate- and low-risk patients with differentiated thyroid cancer (DTC). Understanding the natural history and factors that predict outcome is… read more here.
Keywords: risk; response; intermediate risk; response therapy ... See more keywords
Modalities to enumerate circulating tumor cells in the bloodstream for cancer prognosis and to monitor the response to the therapy.
Sign Up to like & getrecommendations! Published in 2017 at "Drugs of today"
DOI: 10.1358/dot.2017.53.9.2697473
Abstract: Certain malignant cells may detach from the primary tumor and enter the vascular system, forming so-called circulating tumor cells (CTCs). Clusters of malignant cells associated with other cell types can also be observed in the… read more here.
Keywords: response therapy; circulating tumor; tumor cells; tumor ... See more keywords
An immediate postoperative response to therapy assessment can help avoid unnecessary RAI therapy
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.947710
Abstract: Background Radioiodine (RAI) therapy plays a vital role in the postoperative treatment of differentiated thyroid cancer (DTC) patients underwent total thyroidectomy (TT). However, even in the presence of capsular invasion and lymph node metastasis prognosis… read more here.
Keywords: rai therapy; therapy; response therapy; response ... See more keywords